The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Micafungin Sodium for Injection Market Research Report 2024
Synopsis
Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration on March 16, 2005, and gained approval in the European Union on April 25, 2008.
The global Micafungin Sodium for Injection market was valued at US$ 340.7 million in 2023 and is anticipated to reach US$ 286.8 million by 2030, witnessing a CAGR of -2.4% during the forecast period 2024-2030.
North America is the largest Micafungin Sodium for Injection market with about 28% market share. Europe is follower, accounting for about 26% market share.
The key players are Astellas etc. Astellas occupied about 97% market share.
This report aims to provide a comprehensive presentation of the global market for Micafungin Sodium for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Micafungin Sodium for Injection.
Report Scope
The Micafungin Sodium for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Micafungin Sodium for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Micafungin Sodium for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Astellas
Segment by Type
50 mg Single-use Vial
100 mg Single-use Vial
Segment by Application
Candidemia
Respiratory Mycosis
Gastrointestinal Mycosis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Micafungin Sodium for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Micafungin Sodium for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration on March 16, 2005, and gained approval in the European Union on April 25, 2008.
The global Micafungin Sodium for Injection market was valued at US$ 340.7 million in 2023 and is anticipated to reach US$ 286.8 million by 2030, witnessing a CAGR of -2.4% during the forecast period 2024-2030.
North America is the largest Micafungin Sodium for Injection market with about 28% market share. Europe is follower, accounting for about 26% market share.
The key players are Astellas etc. Astellas occupied about 97% market share.
This report aims to provide a comprehensive presentation of the global market for Micafungin Sodium for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Micafungin Sodium for Injection.
Report Scope
The Micafungin Sodium for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Micafungin Sodium for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Micafungin Sodium for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Astellas
Segment by Type
50 mg Single-use Vial
100 mg Single-use Vial
Segment by Application
Candidemia
Respiratory Mycosis
Gastrointestinal Mycosis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Micafungin Sodium for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Micafungin Sodium for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Micafungin Sodium for Injection Market Overview
1.1 Product Overview and Scope of Micafungin Sodium for Injection
1.2 Micafungin Sodium for Injection Segment by Type
1.2.1 Global Micafungin Sodium for Injection Market Value Comparison by Type (2024-2030)
1.2.2 50 mg Single-use Vial
1.2.3 100 mg Single-use Vial
1.3 Micafungin Sodium for Injection Segment by Application
1.3.1 Global Micafungin Sodium for Injection Market Value by Application: (2024-2030)
1.3.2 Candidemia
1.3.3 Respiratory Mycosis
1.3.4 Gastrointestinal Mycosis
1.4 Global Micafungin Sodium for Injection Market Size Estimates and Forecasts
1.4.1 Global Micafungin Sodium for Injection Revenue 2019-2030
1.4.2 Global Micafungin Sodium for Injection Sales 2019-2030
1.4.3 Global Micafungin Sodium for Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Micafungin Sodium for Injection Market Competition by Manufacturers
2.1 Global Micafungin Sodium for Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Micafungin Sodium for Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Micafungin Sodium for Injection Average Price by Manufacturers (2019-2024)
2.4 Global Micafungin Sodium for Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Micafungin Sodium for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Micafungin Sodium for Injection, Product Type & Application
2.7 Micafungin Sodium for Injection Market Competitive Situation and Trends
2.7.1 Micafungin Sodium for Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Micafungin Sodium for Injection Players Market Share by Revenue
2.7.3 Global Micafungin Sodium for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Micafungin Sodium for Injection Retrospective Market Scenario by Region
3.1 Global Micafungin Sodium for Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Micafungin Sodium for Injection Global Micafungin Sodium for Injection Sales by Region: 2019-2030
3.2.1 Global Micafungin Sodium for Injection Sales by Region: 2019-2024
3.2.2 Global Micafungin Sodium for Injection Sales by Region: 2025-2030
3.3 Global Micafungin Sodium for Injection Global Micafungin Sodium for Injection Revenue by Region: 2019-2030
3.3.1 Global Micafungin Sodium for Injection Revenue by Region: 2019-2024
3.3.2 Global Micafungin Sodium for Injection Revenue by Region: 2025-2030
3.4 North America Micafungin Sodium for Injection Market Facts & Figures by Country
3.4.1 North America Micafungin Sodium for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Micafungin Sodium for Injection Sales by Country (2019-2030)
3.4.3 North America Micafungin Sodium for Injection Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Micafungin Sodium for Injection Market Facts & Figures by Country
3.5.1 Europe Micafungin Sodium for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Micafungin Sodium for Injection Sales by Country (2019-2030)
3.5.3 Europe Micafungin Sodium for Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Micafungin Sodium for Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Micafungin Sodium for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Micafungin Sodium for Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Micafungin Sodium for Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Micafungin Sodium for Injection Market Facts & Figures by Country
3.7.1 Latin America Micafungin Sodium for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Micafungin Sodium for Injection Sales by Country (2019-2030)
3.7.3 Latin America Micafungin Sodium for Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Micafungin Sodium for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Micafungin Sodium for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Micafungin Sodium for Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Micafungin Sodium for Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Micafungin Sodium for Injection Sales by Type (2019-2030)
4.1.1 Global Micafungin Sodium for Injection Sales by Type (2019-2024)
4.1.2 Global Micafungin Sodium for Injection Sales by Type (2025-2030)
4.1.3 Global Micafungin Sodium for Injection Sales Market Share by Type (2019-2030)
4.2 Global Micafungin Sodium for Injection Revenue by Type (2019-2030)
4.2.1 Global Micafungin Sodium for Injection Revenue by Type (2019-2024)
4.2.2 Global Micafungin Sodium for Injection Revenue by Type (2025-2030)
4.2.3 Global Micafungin Sodium for Injection Revenue Market Share by Type (2019-2030)
4.3 Global Micafungin Sodium for Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Micafungin Sodium for Injection Sales by Application (2019-2030)
5.1.1 Global Micafungin Sodium for Injection Sales by Application (2019-2024)
5.1.2 Global Micafungin Sodium for Injection Sales by Application (2025-2030)
5.1.3 Global Micafungin Sodium for Injection Sales Market Share by Application (2019-2030)
5.2 Global Micafungin Sodium for Injection Revenue by Application (2019-2030)
5.2.1 Global Micafungin Sodium for Injection Revenue by Application (2019-2024)
5.2.2 Global Micafungin Sodium for Injection Revenue by Application (2025-2030)
5.2.3 Global Micafungin Sodium for Injection Revenue Market Share by Application (2019-2030)
5.3 Global Micafungin Sodium for Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Astellas
6.1.1 Astellas Corporation Information
6.1.2 Astellas Description and Business Overview
6.1.3 Astellas Micafungin Sodium for Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Astellas Micafungin Sodium for Injection Product Portfolio
6.1.5 Astellas Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Micafungin Sodium for Injection Industry Chain Analysis
7.2 Micafungin Sodium for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Micafungin Sodium for Injection Production Mode & Process
7.4 Micafungin Sodium for Injection Sales and Marketing
7.4.1 Micafungin Sodium for Injection Sales Channels
7.4.2 Micafungin Sodium for Injection Distributors
7.5 Micafungin Sodium for Injection Customers
8 Micafungin Sodium for Injection Market Dynamics
8.1 Micafungin Sodium for Injection Industry Trends
8.2 Micafungin Sodium for Injection Market Drivers
8.3 Micafungin Sodium for Injection Market Challenges
8.4 Micafungin Sodium for Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
